Clinical Trial Update: Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine [Phase 1]

View source ↗

Summary

Phase 1, placebo-controlled randomized trial evaluating an adenoviral-vector Norovirus vaccine by Vaxart has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Norovirus Gastroenteritis

Drugs mentioned

• Norovirus vaccine (adenoviral-vector based)

Snippet

Sponsor: Vaxart | Conditions: Norovirus Gastroenteritis | Phase 1 | Status: COMPLETED